ISS unlikely to renew Novartis deal ISS unlikely to renew Novartis deal

The Copenhagen-based facilities services group has made the unusual announcement that its current contract with the pharmaceuticals giant Novartis is unlikely to be extended.

To continue reading this article

Enjoy unlimited access to i-FM and daily news headlines.

SIGNUP for a FREE Lite licence
or a Full licence with access to all the research and resources

If you already have a licence please login below

To request a password reset click here.